Category Specific RSS

News

Cleo’s ovarian cancer blood test proves more effective than CA125 clinical benchmark and ultrasound

A benchmarking study comparing ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV)’s blood test against ultrasound has been published in…

2 years ago

Straker introduces AI Cloud and Verify services amid dwindling revenue and lowered sales

In FY24, AI-driven language and content services provider Straker (ASX: STG) faced market conditions tougher than initially expected, with lower…

2 years ago

AD1 secured contract extension with NSW Government for recruitment tech

The NSW Government has remained loyal to HR tech company AD1 Holdings (ASX: AD1) by ending their contract for 2-years…

2 years ago

From pain to gain: EPO grants PainChek patent in 20 European nations

Medical device company PainChek (ASX: PCK), developer of a smartphone-based pain assessment and monitoring application, has been granted a patent…

2 years ago

Bailador invests $20m in digital healthcare platform Updoc amid growing telehealth adoption

COVID-19 was a turning point for the telehealth industry. In Australia, between 2020 and 2022, more than 100 million telehealth…

2 years ago

Geopolitical tensions and the quest for military superiority motivate nations to invest in hypersonic weapons

According to TechSci Research report, “Hypersonic Weapons Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global…

2 years ago

EMVision analysis confirms hyperacute and acute ischaemia stroke detection capabilities

Ischaemia is a condition in which the blood supply to any part of the body is so severely restricted that…

2 years ago

Genetic Signatures halts development of US respiratory product due to competition

Global molecular diagnostics company Genetic Signatures (ASX: GSS) has decided to halt the development of its EasyScreen Essentials Respiratory Detection…

2 years ago

PYC Therapeutics receives Orphan Drug Designation for ADOA treatment

PYC Therapeutics (ASX: PYC), a clinical-stage biotechnology company, has achieved a significant milestone with the U.S. Food and Drug Administration…

2 years ago

PlaySide Studios to develop Game of Thrones strategy game with Warner Bros

Winter is coming, and a Game of Thrones-themed game by video game developer PlaySide Studios (ASX: PLY) is being developed…

2 years ago